We are now at a point in time where our goals are becoming a reality. With three drugs on the horizon to enter the US market within the next year, we are more than confident that Dawah Pharmaceuticals will become a known competitor in the Sterile Injectable market. We confidently predict that our initial 6 drug portfolio will generate over $1 billion in the next 10 years.
You will find a link to our investor's update video and our latest Investor Report deck. We urge you to review both materials and we are looking for serious investors who are passionate about this industry to be part of the Dawah Pharmaceuticals team.
Contact email@example.com or dial 347-669-1693 for more information.